6th Global NASH Congress

Paid

NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms.

02-03 March 2023

Healthcare

Emerging Immune Modulation Strategies

Paid

The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurodegeneration, fibrosis, autoimmune disorders, and more. Cambridge Healthtech Institute’s symposium on

25-25 September 2023

Healthcare

Neurodegeneration Targets

Paid

Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especially Alzheimer’s and Parkinson’s disease. Neurodegenerative diseases have a dearth of therapeutic opti

26-27 September 2023

Healthcare

Fibrosis and Inflammation

Paid

Fibrosis can be viewed as the end-stage of chronic inflammation. Fibrosis and inflammation are related to the immune system gone awry and both underlie many conditions related to aging and therefore are increasing in prevalence in the US. Cambridge Healthtech Institute's Fibrosis and Inflammation conference continues its fifth year of focusing in t

27-28 September 2023

Healthcare